These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 23389469

  • 1. Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations.
    Aigner J, Smetanay K, Hof H, Sinn HP, Sohn C, Schneeweiss A, Marmé F.
    Ann Surg Oncol; 2013 May; 20(5):1538-44. PubMed ID: 23389469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF.
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M.
    JAMA; 2017 Sep 12; 318(10):918-926. PubMed ID: 28898379
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
    Delpech Y, Bricou A, Lousquy R, Hudry D, Jankowski C, Willecocq C, Thoury A, Loustalot C, Coutant C, Barranger E.
    Ann Surg Oncol; 2013 Aug 12; 20(8):2556-61. PubMed ID: 23456432
    [Abstract] [Full Text] [Related]

  • 16. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
    Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS, Morrow M, Gemignani ML.
    Ann Surg Oncol; 2010 Apr 12; 17(4):1063-8. PubMed ID: 20033325
    [Abstract] [Full Text] [Related]

  • 17. Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.
    Shah-Khan M, Boughey JC.
    Cancer Control; 2012 Oct 12; 19(4):267-76. PubMed ID: 23037494
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
    Maaskant-Braat AJ, Voogd AC, van de Poll-Franse LV, Coebergh JW, Nieuwenhuijzen GA.
    Breast; 2012 Aug 12; 21(4):524-8. PubMed ID: 22516371
    [Abstract] [Full Text] [Related]

  • 20. Potential Impact of the Z0011 Trial on the Omission of Axillary Dissection: A Retrospective Cohort Study.
    Shinzato JY, Serra KP, Eugeni C, Cabello C, Cardoso-Filho C, Zeferino LC.
    Rev Bras Ginecol Obstet; 2021 Apr 12; 43(4):297-303. PubMed ID: 33784760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.